The Management of T1G3 Bladder Cancer

Publisher： Karger

E-ISSN： 1423-0399|69|4|263-265

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.69, Iss.4, 2002-11, pp. : 263-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravesical Gemcitabine in BCG-Refractory T1G3 Transitional Cell Carcinoma of the Bladder: A Pilot Study

By  

Urologia Internationalis, Vol. 76, Iss. 2, 2006-02 ,pp. : 106-111

Karger

Access to resources Recommend Favorite

Recurrence and Progression of T1G3 Transitional Cell Carcinoma of the Bladder Treated with Intravesical Bacillus Calmette-Guérin

By  

Urologia Internationalis, Vol. 75, Iss. 2, 2008-07 ,pp. : 107-113

Karger

Access to resources Recommend Favorite

Association of Urokinase Gene 3′-UTR T/C Polymorphism with Bladder Cancer

By  

Urologia Internationalis, Vol. 77, Iss. 1, 2009-05 ,pp. : 81-84

Karger

Access to resources Recommend Favorite

Intravesical Bacillus Calmette-Guérin Therapy for T1 Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 80, Iss. 1, 2008-01 ,pp. : 74-79

Karger

Access to resources Recommend Favorite

The Prognostic Value of T1 Bladder Cancer Substaging: A Single Institution Retrospective Study

By  

Urologia Internationalis, Vol. 92, Iss. 2, 2014-01 ,pp. : 150-156

Karger

Access to resources Recommend Favorite